These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14552796)

  • 1. Enantiomerically pure tetrahydroquinoline derivatives as in vivo potent antagonists of the glycine binding site associated to the NMDA receptor.
    Di Fabio R; Tranquillini E; Bertani B; Alvaro G; Micheli F; Sabbatini F; Pizzi MD; Pentassuglia G; Pasquarello A; Messeri T; Donati D; Ratti E; Arban R; Dal Forno G; Reggiani A; Barnaby RJ
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3863-6. PubMed ID: 14552796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzoazepine derivative as potent antagonists of the glycine binding site associated to the NMDA receptor.
    Di Fabio R; Micheli F; Baraldi D; Bertani B; Conti N; Dal Forno G; Feriani A; Donati D; Marchioro C; Messeri T; Missio A; Pasquarello A; Pentassuglia G; Pizzi DA; Provera S; Quaglia AM; Sabbatini FM
    Farmaco; 2003 Sep; 58(9):723-38. PubMed ID: 13679166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia.
    Di Fabio R; Conti N; De Magistris E; Feriani A; Provera S; Sabbatini FM; Reggiani A; Rovatti L; Barnaby RJ
    J Med Chem; 1999 Sep; 42(18):3486-93. PubMed ID: 10479281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
    Tatlisumak T; Takano K; Meiler MR; Fisher M
    Acta Neurochir Suppl; 2000; 76():331-3. PubMed ID: 11450037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
    Tatlisumak T; Takano K; Meiler MR; Fisher M
    Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SM-31900, a novel NMDA receptor glycine-binding site antagonist, reduces infarct volume induced by permanent middle cerebral artery occlusion in spontaneously hypertensive rats.
    Ohtani K; Tanaka H; Ohno Y
    Neurochem Int; 2003 Apr; 42(5):375-84. PubMed ID: 12510020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZD 9379.
    Drugs R D; 1999 Jan; 1(1):44-5. PubMed ID: 10565985
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists.
    Warner DS; Martin H; Ludwig P; McAllister A; Keana JF; Weber E
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):188-96. PubMed ID: 7860652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
    Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dantrolene antagonizes the glycineB site of the NMDA receptor.
    Salinska E; Sobczuk A; Lazarewicz JW
    Neurosci Lett; 2008 Feb; 432(2):137-40. PubMed ID: 18191027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor.
    Katayama S; Ae N; Kodo T; Masumoto S; Hourai S; Tamamura C; Tanaka H; Nagata R
    J Med Chem; 2003 Feb; 46(5):691-701. PubMed ID: 12593650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.
    Leeson PD; Carling RW; Moore KW; Moseley AM; Smith JD; Stevenson G; Chan T; Baker R; Foster AC; Grimwood S
    J Med Chem; 1992 May; 35(11):1954-68. PubMed ID: 1534584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive multivariate modelling of 4-amino-2-carboxytetrahydroquinolines as antagonists of the glycine-site directed NMDA receptor-ion channel complex.
    Mager PP
    Drug Des Discov; 1994 Apr; 11(3):185-96. PubMed ID: 7548634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of functional antagonists at the glycine site of the NMDA receptor.
    Trullas R
    Methods Find Exp Clin Pharmacol; 1997; 19 Suppl A():55-6. PubMed ID: 9403859
    [No Abstract]   [Full Text] [Related]  

  • 18. 2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the NMDA receptor.
    Carling RW; Leeson PD; Moseley AM; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR
    J Med Chem; 1992 May; 35(11):1942-53. PubMed ID: 1534583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization.
    Conti P; Pinto A; Tamborini L; Madsen U; Nielsen B; Bräuner-Osborne H; Hansen KB; Landucci E; Pellegrini-Giampietro DE; De Sarro G; Donato Di Paola E; De Micheli C
    ChemMedChem; 2010 Sep; 5(9):1465-75. PubMed ID: 20665761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
    Banks P; Franks NP; Dickinson R
    Anesthesiology; 2010 Mar; 112(3):614-22. PubMed ID: 20124979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.